Long-term prognosis in patients undergoing redo-isolated aortic valve replacement-Reference-Cited by-同舟云学术

Long-term prognosis in patients undergoing redo-isolated aortic valve replacement

Published:2023-12-11 Issue: Volume: Page:
ISSN:1479-6678
Container-title:Future Cardiology
language:en
Short-container-title:Future Cardiology

Author:

Dokollari Aleksander¹²^ORCID,Torregrossa Gianluca³,Sicouri Serge³,Cameli Matteo⁴,Mandoli Giulia Elena⁴,Kjelstrom Stephanie³,Prifti Edvin⁵,Veshti Altin⁵,Bonacchi Massimo⁶,Gelsomino Sandro¹

Affiliation:

1. Cardiovascular Research Institute Maastricht - CARIM, Maastricht University Medical Centre, Maastricht, Netherlands

2. St. Cardiac Surgery Department, St. Boniface Hospital, University of Manitoba, Winnipeg M3B1W7, Canada

3. Lankenau Institute for Medical Research, Wynnewood, PA 19096, USA

4. Department of Medical Biotechnologies, Division of Cardiology, University Hospital of Siena, Siena, Italy

5. Division of Cardiac Surgery University Hospital Center “Mother Teresa” Tirana Albania

6. Department of Experimental & Clinical Medicine, University of Florence, Firenze, Italy

Abstract

Aim: To evaluate clinical outcomes after redo aortic valve replacement (AVR) with sutured valves, versus valve-in-valve transcatheter aortic valve replacement (ViV-TAVR), versus sutureless valves. Methods: We identified 113 consecutive patients undergoing redo AVR with either ViV-TAVR, redo-sutured and redo-sutureless valves between August 2010 to March 2020. Heart-team made the decision whether patient should undergo redo-sutureless versus ViV-TAVR, versus redo-sutured AVR. Results: Preoperatively, redo-sutured (n = 57), ViV-TAVR (n = 31) and redo-sutureless (n = 25) patients were compared. Postoperatively, after propensity-adjustment analysis, the redo SAVR group had a higher incidence of new postoperative atrial fibrillation (POAF; p = 0.04) compared with redo-sutureless group. Follow-up outcomes analysis did not show differences among groups. Conclusion: Patients undergoing redo-sutureless AVR experienced a higher incidence of POAF compared with patients undergoing redo-sutured.

Publisher

Future Medicine Ltd

Subject

Cardiology and Cardiovascular Medicine,Molecular Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/fca-2023-0050

Reference26 articles.

1. Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery

2. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients

3. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients

4. Long-term Outcomes of Transcatheter Aortic Valve Replacement With the Lotus Valve vs CoreValve/EvolutR

5. Ministernotomy compared to right anterior minithoracotomy for aortic valve surgery.